Implications of Nanotechnology in Modern Drug Delivery Systems for the Diagnosis and Treatment of Cancer
DOI:
https://doi.org/10.37285/ijpsn-aktu.2022-17Abstract
Cancer or malignancy can also be explained as the irregular and anomalous growth of cells that causes every sixth death. The number of new cases of cancer keeps on increasing every year. Top cancer risks for men are lung, prostate, bladder, melanoma (skin cancer), colorectal, and liver cancer. Women are mainly diagnosed with breast, skin, colorectal, ovarian, cervical, and thyroid cancer. At present cancer treatment includes chemotherapy, surgery, and radiation. These conventional methods have several disadvantages including damage to the surrounding normal healthy tissues and the inability to kill all the tumor cells. Nanotechnology which includes nanoscale devices having a size of 1 to 100 nm, can get around these disadvantages of conventional methods for cancer treatment and diagnosis. Nanoscale devices can easily cross blood vessels and can interact with cells at the biomolecular level to deliver an effective treatment against tumors, and various other types of cancers and can also be helpful in the early detection of cancerous cells. Nanoparticles with specific ligands form complexes with malignant cells receptor causing drug accumulation inside these cells. This article is to explore, enlist and summarize the implication of nanotechnology for the betterment of modern medicine administration systems for the diagnostic and curative approach to cancer.
Downloads
Metrics
Keywords:
Nanotechnology, Chemotherapy, Radiation, CancerPublished
How to Cite
Issue
Section
References
Abbas Z, Rehman S. An overview of cancer treatment modalities. Neoplasm. 2018 Sep 19; 1:139-57.
Saini R, Saini S, Sharma S. Nanotechnology: the future medicine. Journal of cutaneous and aesthetic surgery. 2010 Jan;3(1):32.
WangH, Rempel GL.Introduction of polymer nanoparticles for drug delivery applications. J Nanotechnol Nanomed Nanobiotechnol. 2015; 2(008); DOI: 10.24966/NTMB-2044/100008
Terrance R. Nanotechnology for cancer therapy: Recent developments. Eur J Pharm Med Res. 2016;3(11):284-94.
Pucci C, Martinelli C, Ciofani G. Innovative approaches for cancer treatment: Current perspectives and new challenges. ecancermedical science. 2019;13.
Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. Journal of controlled release. 2001 Jan 29;70(1-2):1-20.
Owens III DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. International journal of pharmaceutics. 2006 Jan 3;307(1):93-102.
Du JZ, Du XJ, Mao CQ, Wang J. Tailor-made dual pH-sensitive polymer–doxorubicin nanoparticles for efficient anticancer drug delivery. Journal of the American Chemical Society. 2011 Nov 9;133(44):17560-3.
Tong R, Cheng J. Anticancer polymeric nanomedicines. Journal of Macromolecular Science, Part C: Polymer Reviews. 2007 Aug 1;47(3):345-81.
Cho K, Wang XU, Nie S, Shin DM. Therapeutic nanoparticles for drug delivery in cancer. Clinical cancer research. 2008 Mar 1;14(5):1310-6.
Zhang G, Niu A, Peng S, Jiang M, Tu Y, Li M, Wu C. Formation of novel polymeric nanoparticles. Accounts of chemical research. 2001 Mar 20;34(3):249-56.
Danhier F, Lecouturier N, Vroman B, Jérôme C, Marchand-Brynaert J, Feron O, Préat V. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. Journal of controlled release. 2009 Jan 5;133(1):11-7.
Singh OP, Nehru RM. Nanotechnology and cancer treatment. Asian J Exp Sci. 2008;22(2):6.
Di Paolo A. Liposomal anticancer therapy: pharmacokinetic and clinical aspects. Journal of chemotherapy. 2004 Nov 1;16(sup4):90-3.
Yan F, Xu H, Anker J, Kopelman R, Ross B, Rehemtulla A, Reddy R. Synthesis and characterization of silica-embedded iron oxide nanoparticles for magnetic resonance imaging. Journal of nanoscience and nanotechnology. 2004 Jan 1;4(1-2):72-6.
Vankayala R, Lin CC, Kalluru P, Chiang CS, Hwang KC. Gold nanoshells-mediated bimodal photodynamic and photothermal cancer treatment using ultra-low doses of near-infrared light. Biomaterials. 2014 Jul 1;35(21):5527-38.
Wang L, Yuan Y, Lin S, Huang J, Dai J, Jiang Q, Cheng D, Shuai X. Photothermo-chemotherapy of cancer employing drug leakage-free gold nanoshells. Biomaterials. 2016 Feb 1; 78:40-9.
He H, Pham-Huy LA, Drama P, Xiao D, Zuo P, Pham-Huy C. Carbon nanotubes: applications in pharmacy and medicine. BioMed research international. 2013 Jan 1;2013.
Lay CL, Liu J, Liu Y. Functionalized carbon nanotubes for anticancer drug delivery. Expert review of medical devices. 2011 Sep 1;8(5):561-6.
Peretz S, Regev O. Carbon nanotubes as nanocarriers in medicine. Current Opinion in Colloid & Interface Science. 2012 Dec 1;17(6) :360-8.
Madani SY, Naderi N, Dissanayake O, Tan A, Seifalian AM. A new era of cancer treatment: carbon nanotubes as drug delivery tools. International journal of nanomedicine. 2011; 6:2963.
Digge MS, Moon RS, Gattani SG. Applications of carbon nanotubes in drug delivery: a review. Int. J. PharmTech. Res. 2012;4(2):839-47.
Chen Z, Pierre D, He H, Tan S, Pham-Huy C, Hong H, Huang J. Adsorption behavior of epirubicin hydrochloride on carboxylated carbon nanotubes. International journal of pharmaceutics. 2011 Feb 28;405(1-2):153-61.
Xiao D, Dramou P, He H, Pham-Huy LA, Li H, Yao Y, Pham-Huy C. Magnetic carbon nanotubes: synthesis by a simple solvothermal process and application in magnetic targeted drug delivery system. Journal of Nanoparticle Research. 2012 Jul;14(7):1-2.
Guo R, Shi X. Dendrimers in cancer therapeutics and diagnosis. Current drug metabolism. 2012 Oct 1;13(8):1097-109.
Caminade AM, Turrin CO. Dendrimers for drug delivery. Journal of Materials Chemistry B. 2014;2(26):4055-66.
Yang H. Targeted nanosystems: Advances in targeted dendrimers for cancer therapy. Nanomedicine: Nanotechnology, Biology, and Medicine. 2016 Feb 1;12(2):309-16.
Malik N, Duncan R, Tomalia D, Esfand R, inventors; AVC Holdings Inc, Dendritic NanoTechnologies Inc, assignee. Antineoplastic-dendritic polymer drug delivery system. United States patent application US 10/493,354. 2006 Feb 23.
Cheng Y, Li M, Xu T. Potential of poly (amidoamine) dendrimers as drug carriers of camptothecin based on encapsulation studies. European journal of medicinal chemistry. 2008 Aug 1;43(8):1791-5.
Park JW. Liposome-based drug delivery in breast cancer treatment. Breast Cancer Research. 2002 Jun;4(3):1-5.
Di Paolo A. Liposomal anticancer therapy: pharmacokinetic and clinical aspects. Journal of chemotherapy. 2004 Nov 1;16(sup4):90-3.
Mohammed AR, Weston N, Coombes AG, Fitzgerald M, Perrie Y. Liposome formulation of poorly water-soluble drugs: optimization of drug loading and ESEM analysis of stability. International journal of pharmaceutics. 2004 Nov 5;285(1-2):23-34.
Park K, Kwon IC, Park K. Oral protein delivery: Current status and prospect. Reactive and Functional Polymers. 2011 Mar 1;71(3):280-7.
Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, Samiei M, Kouhi M, Nejati-Koshki K. Liposome: classification, preparation, and applications. Nanoscale research letters. 2013 Dec;8(1):1-9.
Neuberger T, Schöpf B, Hofmann H, Hofmann M, Von Rechenberg B. Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. Journal of Magnetism and Magnetic materials. 2005 May 1;293(1):483-96.
Sun JZ, Sun YC, Sun L. Synthesis of surface-modified Fe3O4 superparamagnetic nanoparticles for ultrasound examination and magnetic resonance imaging for cancer treatment. Journal of Photochemistry and Photobiology B: Biology. 2019 Aug 1; 197:111547.
Sun C, Sze R, Zhang M. Folic acid‐PEG conjugated superparamagnetic nanoparticles for MRI targeted cellular uptake and detection. Journal of Biomedical Materials Research Part A: An Official Journal of The Society for Biomaterials, The Japanese Society for Biomaterials, The Australian Society for Biomaterials, and the Korean Society for Biomaterials. 2006 Sep 1;78(3):550-7.
Hong SP, Kang SH, Kim DK, Kang BS. Paramagnetic nanoparticle-based targeting theranostic agent for c6 rat glioma cell. Journal of Nanomaterials. 2016;2016.
Mogharabi M, Abdollahi M, Faramarzi MA. Toxicity of nanomaterials; and undermined issue.DARU Journal of Pharmaceutical Sciences. 2014; 22:59.
Aillon KL, Xie Y, El-Gendy N, Berkland CJ, Forrest ML. Effects of nanomaterial physicochemical properties on in vivo toxicity. Advanced drug delivery reviews. 2009 Jun 21;61(6):457-66.
Ganguly P, Breen A, Pillai SG. Toxicity of nanomaterials: exposure, pathways, assessment, and recent advances. ACS Biomaterials Science & Engineering. 2018 Jun 8;4(7):2237-75.
Zielińska A, Carreiró F, Oliveira AM, Neves A, Pires B, Venkatesh DN, Durazzo A, Lucarini M, Eder P, Silva AM, Santini A. Polymeric nanoparticles: production, characterization, toxicology, and ecotoxicology. Molecules. 2020Jan;25(16):3731;
doi:10.3390/molecules25163731
Kalele S, Gosavi SW, Urban J, Kulkarni SK. Nanoshell particles: synthesis, properties, and applications. Current science. 2006 Oct 25:1038-52.
Singh I, Rehni AK, Kumar P, Kumar M, Aboul‐Enein HY. Carbon nanotubes: synthesis, properties, and pharmaceutical applications. Fullerenes, Nanotubes and Carbon Nanostructures. 2009 Jul 1;17(4):361-77.
Cancan Jin, Kankai Wang, Anthony Oppong-Gyebi, Jiangnan Hu. Various types of gold nanoparticles (different sizes, morphologies, and ligands) accumulate in tumor tissues by the action of the osmotic tension effect (termed Passive targeting) or localize to specific cancer cells in a ligand-receptor binding way 2020.10.18
Azar NT, Mutlu P, Khodadust R, Gunduz U. Poly (amidoamine)(PAMAM) nanoparticles: Synthesis and biomedical applications. J. Biol. Chem. 2013;41(3):289-99.
Olusanya TO, Haj Ahmad RR, Ibegbu DM, Smith JR, Elkordy AA. Liposomal drug delivery systems and anticancer drugs. Molecules. 2018 Apr;23(4):907.
Bakhtiary Z, Saei AA, Hajipour MJ, Raoufi M, Vermesh O, Mahmoudi M. Targeted superparamagnetic iron oxide nanoparticles for early detection of cancer: Possibilities and challenges. Nanomedicine: Nanotechnology, Biology, and Medicine. 2016 Feb 1;12(2):287-307.
Memorial Sloan Kettering Cancer CenterThe Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer 2020 Mar 9
Cancer Institute and Hospital, Chinese Academy of Medical Sciences Carbon Nanoparticles and Indocyanine Green Sentinel Lymph Node Biopsy in Early Stage Cervical Cancer, 2021 Dec 22.
Amina Fouad Farag Diagnostic and Prognostic Accuracy of Gold Nanoparticles in Salivary Gland Tumours 2021 Sep 1.
SCRI Development Innovations, LLC Nanoparticle Albumin-Bound (Nab) Paclitaxel/Cyclophosphamide in Early Stage Breast .Cancer Treatment 2021 Nov 24.
Mayo clinic, NCIABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastaticbreast cancer. 2011 Jun 2.
Nanospectra Biosciences, Inc MRI/US Fusion Imaging, and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue. 2016 Feb 11.
National Institutes of Health Clinical Centre (NCI), Combining CRLX101, a Nanoparticle Camptothecin, With Enzalutamide in People with Progressive Metastatic Castration-Resistant Prostate Cancer Following Prior Enzalutamide treatment 2022 Feb 8.
City of Hope Medical Centre, National Cancer Institute (NCI), Treating Patients with Advanced Cancer of the Peritoneal Cavity, 2018 Jan 19.
Jun Zhang, Ruijin Hospital, therapy inpatient with Gastric cancer 3rd Stage, 2021 Mar 4.
Kirichenko A,SingerA. Research Institute, Radiotherapy with Iron Oxide Nanoparticles (SPION) on MR-LINAC for Primary & Metastatic Cancer. (2021)
NanoCarrier Co., Ltd, Combination Therapy with NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer. (2020).
